Update on Berberine in Nonalcoholic Fatty Liver Disease

@inproceedings{Liu2013UpdateOB,
  title={Update on Berberine in Nonalcoholic Fatty Liver Disease},
  author={Yang Liu and Li Zhang and Haiyan Song and Guang Ji},
  booktitle={Evidence-based complementary and alternative medicine : eCAM},
  year={2013}
}
Berberine (BBR), an active ingredient from nature plants, has demonstrated multiple biological activities and pharmacological effects in a series of metabolic diseases including nonalcoholic fatty liver disease (NAFLD). The recent literature points out that BBR may be a potential drug for NAFLD in both experimental models and clinical trials. This review highlights important discoveries of BBR in this increasing disease and addresses the relevant targets of BBR on NAFLD which links to insulin… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

An Insight into Ginsenoside Metabolite Compound K as a Potential Tool for Skin Disorder

Evidence-based complementary and alternative medicine : eCAM • 2018
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 72 references

Berberine suppresses Th17 and dendritic cell responses.

Investigative ophthalmology & visual science • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…